Monoclonal Antibody Infusion Kit for Rheumatoid Arthritis from Germany
This kit contains rituximab, a monoclonal antibody, pre-filled in measured-dose syringes for intravenous infusion to treat rheumatoid arthritis. It qualifies under HTS 3002.15.00.91 as an immunological product (peptide/protein regulating immunological processes) put up in measured doses for retail sale. Biotechnologically produced and modified for therapeutic use.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Maintain strict cold chain documentation (2-8°C) with temperature logs to prevent spoilage claims at customs
• Provide FDA approval letters and biotech production certificates; misclassification as non-immunological risks penalties
• Declare exact measured doses per package; retail packing distinguishes from bulk under 3002.10